Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of everolimus to SAve REnal Function (SAREFU) in long term heart transplanted patients

Next Previous
Trial Profile

Efficacy and safety of everolimus to SAve REnal Function (SAREFU) in long term heart transplanted patients

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Everolimus (Primary) ; ACE inhibitors; Ciclosporin
  • Indications Heart transplant rejection
  • Focus Adverse reactions
  • Acronyms SAREFU

Most Recent Events

  • 27 Apr 2013 Results at 5 years presented at the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
  • 14 Apr 2011 Three-year results presented at the 31st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
  • 05 May 2010 Two-year primary endpoint results presented at the American Transplant Congress -- 10th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation (ATC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top